A Phase II Study to Evaluate the Efficacy of Ramosetron, Aprepitant, and Dexamethasone in Preventing Cisplatin-Induced Nausea and Vomiting in Chemotherapy-Naïve Cancer Patients

PURPOSE: Combination therapy with aprepitant, serotonin receptor antagonist, and steroids improves the complete response rate of both acute and delayed chemotherapy-induced nausea and vomiting (CINV). However, it is not known whether ramosetron is suitable for administration in combination with apre...

Descripción completa

Detalles Bibliográficos
Autores principales: Jang, Geundoo, Song, Hun Ho, Park, Keon Uk, Kim, Hyeong Su, Choi, Dae Ro, Kwon, Jung Hye, Kim, Ho Young, Han, Boram, Kim, Jung Han, Jung, Joo Young, Kim, Hyo Jung, Zang, Dae Young
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Korean Cancer Association 2013
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3804728/
https://www.ncbi.nlm.nih.gov/pubmed/24155675
http://dx.doi.org/10.4143/crt.2013.45.3.172

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3804728/
https://www.ncbi.nlm.nih.gov/pubmed/24155675
http://dx.doi.org/10.4143/crt.2013.45.3.172

Ejemplares similares